Meeting abstract
https://doi.org/10.26800/LV-144-supl2-CR60
Pemetrexed treatment for adenocarcinoma of un- known primary origin with BAP-1 mutation – imple- menting NGS analysis into clinical practice
Andrea Racetin
; School of Medicine University of Zagreb
Borislav Belev
; University Hospital Centre Zagreb
Abstract
Genome analysis like „Next-generation sequencing“ (NGS) has impacted research of complex diseases including cancer. NGS allowed a cost and time-effective sequencing of tumor DNA, introducing us to a „genomic era“ of cancer research and treatment.
Keywords
BAP-1 mutation, Next-generation sequenc- ing (NGS), pemetrexed
Hrčak ID:
279824
URI
Publication date:
27.4.2022.
Visits: 409 *